Each entry submitted into the QiC Hepatitis C awards programme will be reviewed by a multidisciplinary panel of leading hepatitis C experts.
Entries must be well thought through with clear objectives, results, measurable outcomes and conclusions that are specifically related to the aim of the initiative. Projects should have a demonstrable impact on clinical practice, showing how innovation can contribute to the optimisation of service delivery, ultimately benefiting people with hepatitis C.
Judges will favour projects that demonstrate results having quality and/or efficiency benefits which could be replicated elsewhere, thereby having a greater impact than their initial focus.
Embrace this opportunity to be recognised and rewarded for your best practice initiatives and hard work and have the opportunity to share your work with eminent hepatitis C professionals, representatives from patient groups, the NHS and industry.
Once the entry deadline has passed, entries will be reviewed by a panel of judges made up of nurses, patient representatives, policy advisers, clinicians and pharmacists and scored against the judging criteria.
PMGroup will keep all information provided confidential and all judges will sign a confidentiality agreement prior to appointment. Entrants may mark certain sensitive parts of their entry 'not for publication', provided such restrictions are not used unreasonably.
Shortlisted entries will be announced after the judging day and finalists will be invited to attend an awards ceremony, where the winners will be announced.
If you are interested in joining the judging panel please contact Debbie Tuesley (email@example.com) or phone +44 (0)1372 414253.